Par Drugs And Chemicals Limited has informed the Exchange regarding Re-Appointment of Mrs BINTAL BHAVESHKUMAR SHAH as Non- Executive Independent Director of the company w.e.f. September 28, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited held its 26th Annual General Meeting on September 27, 2025, in Vadodara, Gujarat, and all seven resolutions were passed with the required majority. Shareholders approved the audited financial statements for FY ending March 31, 2025 with 99.99% in favour. Mr. Falgun Vallabhbhai Savani (Chairman and Managing Director) was re-appointed via retirement by rotation with 93.74% support. Statutory auditors M/s. Sarupria Somani & Associates were re-appointed for another term with 99.85% approval. M/s DG Patel & Associates were appointed as Secretarial Auditors for a five-year term (FY 2025-26 to FY 2029-30). Mrs. Bintal Bhaveshkumar Shah was re-appointed as an Independent Director for a second term of five years, from September 28, 2025 to September 27, 2030, with 99.85% approval. The meeting saw 42 shareholders participate, representing about 75% of total share capital in voting on most items.
This is a routine AGM outcome with all routine re-appointments and resolutions passing with strong shareholder support. No material governance changes for shareholders, and the high approval margins (mostly above 99%) suggest no notable dissent on any agenda item.